WinstonWınston
Back
Drägerwerk AG & Co. KGaA logo

Drägerwerk AG & Co. KGaA

DRW8.DE
56
Medical - Devices · Healthcare
Price
€82.20
+0.60 (+0.74%)
Market Cap
€2.03B
Exchange
Frankfurt Stock Exchange
Winston Score
56
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Good
Cash Flow
Strong
Stability
Exceptional
Valuation
Strong
Dividends
Good

Winston Score History

The full picture

Drägerwerk is a German company that makes safety and medical equipment. Its main products include breathing machines used in hospitals (called ventilators), anesthesia systems for surgeries, and gas detection devices that warn workers about dangerous air in places like mines, chemical plants, and oil rigs. Its customers are hospitals, emergency services, and industrial companies around the world.

The company earns money by selling its devices and also through long-term service contracts and spare parts, which provide steady recurring revenue. Drägerwerk operates globally, with strong roots in Europe but significant sales in the Americas, Asia, and the Middle East. Its moat comes from deep regulatory expertise, long customer relationships, and the high cost of switching away from certified safety equipment. The main risk the company faces is its relatively thin operating margin, which leaves little room for error if raw material costs rise or hospital spending slows in key markets.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+8.6% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+156.7% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

€319M/ year

Flat (-4% vs prior year)

9.2% of revenue

Below sector average (18%)

Steady R&D investment year-over-year

Insider Activity

76.6%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

€344M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Drägerwerk AG & Co. KGaA is growing revenue at 9% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

0.1% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 18.8M (2021) → 18.7M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
0.0%
Thin — 0.0% gross margin
Profit after running costs
Operating Margin
5.4%
Thin — 5.4% operating margin
Return on the money invested
ROCE
14.6%
Good — 14.6% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+6.4%
Slow sales growth (+6.4% YoY)
Profit growth
EPS YoY
+71.6%
Earnings growing fast (+71.6% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
143%
Turns 143% of profit into real cash
Spare cash per sale
FCF Margin
4.5%
Thin free cash flow (4.5%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.14
Conservative — low debt load (0.14)
Covers its interest
Interest Cover
12.28x
Comfortably covers interest (12.3x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
9.0x
Attractive valuation — P/E 9.0

P/E under 10. The price tag is small relative to last year's profit.

Cheaper or dearer next year
P/E vs Forward
+0.9
GROWING
Earnings roughly flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
2.00%
Small dividend — 2.00% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
+1063.5%
Dividend growing fast (1063.5% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial